Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schleuning

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Bone Marrow Transplantation|October 6, 2015
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantationZ Jedlickova, C Schmid, C Koenecke, et al.
Infection|April 29, 1999
Human parvovirus B19-associated disease in bone marrow transplantationM Schleuning, G Jäger, E Holler, et al.
Bone Marrow Transplantation|January 8, 2008
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remissionC Schmid, M Schleuning, M Hentrich, et al.
Transfusion|May 1, 1988
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantationM U Heim, M Schleuning, R Eckstein, et al.
Blood|August 1, 1995
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)E Holler, H J Kolb, J Mittermüller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Bone Marrow Transplantation|March 2, 2011
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot studyC Schmid, M Schleuning, J Tischer, et al.
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Leukemia|July 12, 2013
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantationE M Weissinger, J Metzger, C Dobbelstein, et al.
Leukemia|October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approachT Burmeister, J Maurer, M Aivado, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bone Marrow Transplantation|October 6, 2015
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantationZ Jedlickova, C Schmid, C Koenecke, et al.
Infection|April 29, 1999
Human parvovirus B19-associated disease in bone marrow transplantationM Schleuning, G Jäger, E Holler, et al.
Bone Marrow Transplantation|January 8, 2008
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remissionC Schmid, M Schleuning, M Hentrich, et al.
Transfusion|May 1, 1988
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantationM U Heim, M Schleuning, R Eckstein, et al.
Blood|August 1, 1995
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)E Holler, H J Kolb, J Mittermüller, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMTC Koenecke, B Hertenstein, J Schetelig, et al.
Bone Marrow Transplantation|March 2, 2011
Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot studyC Schmid, M Schleuning, J Tischer, et al.
Bone Marrow Transplantation|August 6, 2003
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)A R Zander, N Kröger, M Schleuning, et al.
Leukemia|July 12, 2013
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantationE M Weissinger, J Metzger, C Dobbelstein, et al.
Leukemia|October 6, 2000
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approachT Burmeister, J Maurer, M Aivado, et al.
Pageof 4